JORDAN MENGE: Open Payments
NPI 1538936323 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 48 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,031 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 5 | $309 |
| GENZYME CORPORATION | 5 | $190 |
| Amgen Inc. | 8 | $169 |
| Galderma Laboratories, L.P. | 4 | $120 |
| ABBVIE INC. | 4 | $74 |
| PFIZER INC. | 3 | $56 |
| Incyte Corporation | 2 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $49 |
| Lilly USA, LLC | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
Products named: Zoryve, DUPIXENT, OTEZLA, SKYRIZI, AKLIEF, NEMLUVIO, CIBINQO, OPZELURA.
Industry payments across MD — which companies pay providers there.
